BioSpace News Archive

FDA

FDA approves Dupixent® (dupilumab) for moderate-to-severe atopic dermatitis in adolescents - March 11, 2019

In a Phase 3 trial, Dupixent significantly reduced the extent and severity of disease and itching, and helped adolescents achieve clearer skin

March 11, 2019
·
18 min read
Pharm Country

Axovant Announces Clinical Update from First Tay-Sachs Disease Patient Dosed with AXO-AAV-GM2 Gene Therapy

Generally well-tolerated with no serious adverse events in a 30-month-old patient with advanced infantile Tay-Sachs disease

March 11, 2019
·
7 min read
Drug Development

Axovant Reports Positive Interim Results from First Cohort of SUNRISE-PD Phase 2 Trial of AXO-Lenti-PD Gene Therapy in Parkinson’s Disease

25-point (42%) mean improvement in the UPDRS Part III (motor) OFF score, with individual patient improvements of 14 points and 36 points respectively

March 11, 2019
·
9 min read
Business

ASLAN PHARMACEUTICALS SIGNS NEW AGREEMENT WITH BIOGENETICS FOR COMMERCIALISATION OF ASLAN003 IN SOUTH KOREA

ASLAN will grant BioGenetics exclusive rights to commercialise ASLAN003 in South Korea in exchange for an upfront payment of US$1 million and up to US$8 million in sales and development milestones.

March 11, 2019
·
6 min read
Business

Chi-Med Reports 2018 Full Year Results and Provides Updates on Key Clinical Programs

Video webcast presentation at 9:00 a.m. GMT and additional conference call at 9:00 a.m. EDT.

March 11, 2019
·
23 min read
Business

Varian Announces Second Quarter Fiscal Year 2019 Earnings Release Date and Upcoming Investor Event

Varian announced its second quarter fiscal year 2019 earnings release date and upcoming investor event.

March 11, 2019
·
1 min read
Biotech Bay

AcelRx Pharmaceuticals to Present at Oppenheimer & Co. Inc. 29th Annual Healthcare Conference

AcelRx Pharmaceuticals, Inc. announced that management will be presenting at the Oppenheimer 29th Annual Healthcare Conference to be held March 19 – 20.

March 11, 2019
·
2 min read
Business

BIO Statement on President’s Proposed 2020 Budget

Biotechnology Innovation Organization President and CEO Jim Greenwood issued the following statement regarding President Trump’s FY 2020 budget proposal

March 11, 2019
·
2 min read
BioMidwest

Nationally-recognized orthopedic surgeons make special presentations in OBERD booth 4262 at AAOS national conference

Proven uses of new technology and the ShoulderJam registry for highly efficient surgery data collection and performance benchmarking

March 11, 2019
·
1 min read
Policy

Investor Alert: Kaplan Fox Announces Investigation Of American Renal Associates Holdings

Kaplan Fox & Kilsheimer LLP is investigating claims on behalf of investors of American Renal Associates Holdings, Inc., a company that through its subsidiaries owns and operates kidney dialysis centers.

March 11, 2019
·
1 min read